PICALM and early-onset autosomal dominant Alzheimer disease: On the one hand, CALM appears to serve as endocytic adaptor for the uptake of APP, potentially in conjunction with other adaptors such as Numb [129], thereby modulating the trafficking and proteolytic processing of APP [130] and increasing the plaque load in an Alzheimer’s disease mouse model upon CALM overexpression [130].